Peter Kaiser, MD
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Neil Bressler, MD
Johns Hopkins University School of Medicine
Baltimore, MD
David Brown, MD
Retina Consultants of Texas
Houston, TX
Diana Do, MD
Byers Eye Institute, Stanford University
Palo Alto, CA
Biosimilars have impacted the treatment options now available across various medical conditions. Join Biogen for an engaging breakfast panel forum as our distinguished faculty lead a discussion on the role of biosimilars, with a particular focus on wet age-related macular degeneration (AMD). The interactive faculty panel will cover several topics including real world experience and integration of biosimilars into clinical practice.
Education Objectives
This event is not affiliated with the official program of AAO 2022.